These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12494544)

  • 21. [Spastic tetraparesis and heart thrombus in a male patient as first symptoms of the antiphospholipid syndrome].
    Bobrowska-Snarska D; Ostanek L; Płońska E; Brzosko M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():75-9. PubMed ID: 17471840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal artery thrombosis revealing antiphospholipid antibody syndrome].
    Arache W; Bahadi A; Kabbaj DE
    Pan Afr Med J; 2018; 31():150. PubMed ID: 31037210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral venous thrombosis as the presenting symptom of systemic lupus erythematosus].
    Cardona-Portela P; Casasnovas-Pons C; Moral-Torres M; Rubio-Borrego F
    Rev Neurol; 2004 Jul 1-15; 39(1):30-4. PubMed ID: 15257524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A possible solution to the paradox of the "lupus anticoagulant": antiphospholipid antibodies accelerate thrombin generation by inhibiting annexin-V.
    Rand JH; Wu XX; Giesen P
    Thromb Haemost; 1999 Oct; 82(4):1376-7. PubMed ID: 10544942
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric cerebellar stroke associated with elevated titer of antibodies to β2-glycoprotein.
    Spalice A; Del Balzo F; Perla FM; Papetti L; Nicita F; Ursitti F; Properzi E
    Med Hypotheses; 2011 Jun; 76(6):831-3. PubMed ID: 21388749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "lupus" circulating anticoagulant, AKA the primary antiphospholipid syndrome.
    Rothschild BM
    Compr Ther; 1996 Jul; 22(7):420-3. PubMed ID: 8866192
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk.
    Lecompte T; Wahl D; Perret-Guillaume C; Hemker HC; Lacolley P; Regnault V
    Haematologica; 2007 May; 92(5):714-5. PubMed ID: 17488705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical consequences of antiphospholipid antibodies.
    Derksen RH; de Groot PG
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on antiphospholipid syndrome.
    Lockshin MD
    Bull NYU Hosp Jt Dis; 2008; 66(3):195-7. PubMed ID: 18937631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests.
    Galli M; Barbui T
    Semin Thromb Hemost; 2005 Feb; 31(1):17-24. PubMed ID: 15706471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.